IPG Photonics rethinks its segments as battery-driven demand powers a 17% quarter — but tariffs and a 42% drawdown test the story

IPG Photonics rethinks its segments as battery-driven demand powers a 17% quarter — but tariffs and a 42% drawdown test the story

IPG Photonics reported a solid first quarter — revenue up 17% year-over-year to $265 million, with “First quarter revenue exceeded our expectations, increasing 17% year-over-year” — Mark Gitin, CEO · 2026-05-05 — and a second consecutive quarter of book-to-bill above 1. The company also unveiled a new revenue reporting framework, splitting the business into Industrial Solutions and Advanced Solutions. This is a strategic pivot in presentation, giving investors clearer visibility into where growth is coming from and where the company is investing.

The framework aligns directly with the demand drivers management stressed on the call. In Industrial Solutions, battery manufacturing — particularly for stationary storage serving data centers — drove welding and cutting growth. As CEO Mark Gitin said, “We continue to see improved demand for our laser solutions, particularly in battery manufacturing and medical applications, which drove our strong performance in the quarter.” — Mark Gitin, CEO · 2026-05-05 The stationary storage angle is significant because it links IPG to the broader data-center power theme. The company also highlighted semiconductor applications as a new growth vector, with revenue ramping from lithography, metrology, and inspection wins. In Advanced Solutions, medical and defense remain key, with the $10 million Lockheed Martin follow-on order for the Crossbow laser system.

Growth, however, is being partially offset by tariffs. The company guided to a ~150-basis-point tariff headwind in Q2, and gross margin came in at 37.5% GAAP (37.8% adjusted). CFO Tim Mammen reiterated the mid-40s long-term margin target but acknowledged the pressure:

Although first quarter gross margin was a little light given the level of revenue, we continue to strive for margin increases through cost reductions, pricing initiatives and reducing underabsorbed costs.

The market has not rewarded this progress. The stock is down 42.5% over the last 90 days, according to the price tape. That is an outsized decline for a company reporting accelerating revenue and record bookings. While tariffs and the uncertain macro environment are obvious concerns, the magnitude of the drawdown suggests investors are pricing in a tougher second half, as the company itself flagged tougher comparisons after a strong 2025. The valuation has compressed sharply — price-to-revenue sits at 4.7x versus a peak near 10x in 2020, and gross margin remains far below its 2018 peak of 57%.

Management's confidence is anchored in the differentiation of its laser solutions. On a prior call, Mark Gitin said: “What we have said to date is that we expect to see growth in that area of hundreds of millions of dollars over the next several years” — Mark Gitin, Executive (likely CEO or similar senior executive) · 2026-02-12 — referring to the medical, micromachining, and defense TAM. The company's ability to execute on that roadmap, while managing tariff and absorption costs, will determine whether the market's skepticism is warranted. The new segment framework clarifies the path, but the stock's slide signals that investors want to see margin leverage, not just top-line momentum.